Complications of ECLS. Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky

Size: px
Start display at page:

Download "Complications of ECLS. Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky"

Transcription

1 Complications of ECLS Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky

2 Faculty Disclosure No financial Disclosures

3 Education Need/Practice Gap Recommendations and guidelines regarding complications in ECLS are difficult to find. Providers need to be aware of the possible risks of ECLS.

4 Objectives Upon completion of this educational activity, you will be able to: 1. Indicate common complications of ECLS. 2. Recognize, intervene early, and alter management based on the complication

5 Expected Outcomes The desired change/result in practice is to be aware of the major complications or injuries that can occur with ECLS.

6 Overview Immediate Complications with Cannulation and Initiation Delayed Bleeding and Thrombotic Complications Delayed Organ System Failure: Renal failure Other complications: Air Embolism

7 Major Vascular Complications Difficulty with this topic is it is under reported in the literature Publication Bias Perforation of Major vessel, or dissection of an artery are known complications Incidence of these complications is fortunately low. However, it is usually fatal and since ECLS was never initiated not reported in the ELSO Registry! One frequently has to go to international journals to find literature.

8 Venous Injury During Insertion 1. Perforation of the left Iliac Vein 2. Right Internal Jugular vein at the thoracic inlet 3. Right Subclavian Vein: would not use for ECLS! 4. One paper reported traumatic rupture of the IVC with death of the patient 5. Another instance of implantation of the arterial cannula into the femoral vein.

9 Arterial Injury Most frequent serious problem is dissection A localized dissection can often be managed An extensive dissection is frequently fatal One may note poor flows on ECMO or high pressures on the circuit No blood return from the arterial cannula may also be noted Fortunately major injuries are rare, while localized dissections are not uncommon

10 Underlying Cause of Vascular Injuries Failure to use Modified Seldinger Kinked guide wire Atherosclerosis or tortuosity Emergent circumstances leading to rushing

11 General Principle of Management Buy Time Leave cannula in place, and secure it, and clamp it Alternative access for ECMO and stabilize patient Then consult Interventional, Vascular Surgery If time permits, imaging study (Fluoroscopy, TEE, or CT)

12 Lower Extremity Ischemia Pulseless/Cold Leg Compartment Syndrome

13 Distal Perfusion Catheter

14 Compartment Syndrome Often noted after reperfusion of the leg with restoration of pulses However, compartment pressures above 20 mm Hg require urgent fasciotomy Compartment syndrome is due to venous obstruction due to swelling and will result in irreversible neurologic injury and muscle necrosis if it is not treated promptly

15 Normal Pulses in Compartment Syndrome

16 Tight Calf Compartment

17 Compartment Pressure Above 20

18 Biochemical Evidence of Ischemia Increasing Lactate Increased CPKs (frequently well above 10,000) Finally leading to rhabdomyolysis, myoglobinuria, renal failure, hyperkalemia

19 Bleeding Complications Can occur anywhere from Cannula insertion sites, surgical incisions, lung, gi tract, nose, mouth, thorax, abdomen, and brain. Causes: Heparin effect, overdose, coagulopathy, thrombocytopenia, platelet dysfunction, acquired VWS, Hyperfibrinolysis.

20 Intracranial Bleeding Wide range with a frequency between 1.8% to 21%. Higher incidence occurs with routine CT scans Increase is associated with prolonged duration, antithrombotic therapy, altered intrinsic coagulation, renal failure, need of blood products. In the H1N1 pandemic in Australia and Newzealand, ICH was the most common cause of death among ECMO treated patients. In large series, relative risk of death is 1.48 to However, modality of ECMO does not seem to make a difference

21 Reducing ICH Unproven: 1. Lowering ACT goals, prophylactic correction of coagulation factor deficiencies, possible use of Enoxaparin exclusively, low dose anticoagulation 2. There is evidence in pediatric and neonatal patients that certain biomarkers may be elevated prior to imaging detection of ICH (S100B, NSE, GFAP and others). 3. One Swedish study found that pre admission antithrombotic therapy and low plt count were independently associated with a high mortality with ICH

22 G.I. Bleeding Kiefer et al from Maryland found a 13.6% incidence of GI bleeding Duration of ECLS (12 days vs 7 days) was a factor Higher inhospital mortality (83% vs 44%). Odds ratio of 5.91 for in hospital mortality Most frequent diagnosis was stress gastritis. Cause thought to be coagulopathy, systemic inflammation, non pulsatile blood flow In a Canadian paper by Cook et al., regarding stress ulcer prophylaxis, studying 2252 critically ill patients, patients with respiratory failure (odds ratio of 15.6) and coagulopathy (odds ratio of 4.3) were most likely to encounter gi bleeding. ECMO patients seems to be thus the highest risk population for gi bleeding

23 Acquired VW Syndrome in ECLS Patients AVWS associated with loss of HMW multimers of VWF, leading to impaired binding of VWF to platelets This was studied in 32 patients with ECLS and 19 without. Ratios of ristocetin cofactor activity and collagen binding capacity to VWF antigen and multimeric analysis were performed 31/32 ECLS patients presented with AVWS, but none of the patients without it.

24 Thrombotic Complications High fibrinogen, Factor VIII levels, heparin resistance, and platelet activation LV thrombus may occur in cases of VA ECMO if there is minimal ejection Interaction between PVWF and PfHb may explain thrombosis Circuit Clots

25 Renal Failure Incidence is 30-40% In a review of multiple studies, OR for mortality of ECMO and CRRT was about 6.

26 Survival with Kidney Injury C. Delmas et al. / Journal of Critical Care 44 (2018) Patients' outcome at 30 days and 3 months (M3) according to groups 1 and 2. Group 1: No AKI, AKI KDIGO stages 1 and 2 patients (n = 31); group 2: AKI KDIGO stage 3 patients (n = 29) * and α p b 0.05.

27 Uncommon Complications Massive Air Embolism Can Occur even during routine care of the central line Air can enter the venous system, and then the oxygenator, and the arterial line, resulting in immediate shut down of the circuit, and air embolism to the arterial side Can also result from a PFO or a Bubble Study

28 Air Embolism from a Central Line

29 Conclusions 1. ECLS is a modality with high morbidity and mortality 2. Complications occur from insertion, to mechanical problems, to bleeding and thrombotic events remote from cannulation 3. When they occur, they often require specialized personnel to manage them 4. A team approach to monitoring and early intervention is necessary to mitigate complications and their morbidity

Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure

Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Introduction This pediatric respiratory failure guideline is a supplement to ELSO s General Guidelines for all

More information

ECMO BASICS CHLOE STEINSHOUER, MD PULMONARY AND SLEEP CONSULTANTS OF KANSAS

ECMO BASICS CHLOE STEINSHOUER, MD PULMONARY AND SLEEP CONSULTANTS OF KANSAS ECMO BASICS CHLOE STEINSHOUER, MD PULMONARY AND SLEEP CONSULTANTS OF KANSAS DISCLOSURES No financial disclosures or conflicts of interest OBJECTIVES Define ECMO/ECLS and be able to identify the main types

More information

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan ECMO as a bridge to durable LVAD therapy Jonathan Haft, MD Department of Cardiac Surgery University of Michigan Systolic Heart Failure Prevalence 4.8 million U.S. 287,000 deaths per year $39 billion spent

More information

To ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW

To ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW To ECMO Or Not To ECMO Challenges of venous arterial ECMO Dr Emily Granger St Vincent s Hospital Darlinghurst NSW The Start: 1972 St Vincent s Hospital The Turning Point ECMO program restarted in 2004

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

Nursing Process Focus: Patients Receiving Heparin

Nursing Process Focus: Patients Receiving Heparin Obtain complete heath history including allergies, drug history and possible drug Assess baseline coagulation studies and CBC. Assess for history of bleeding disorders, GI bleeding, cerebral bleed, recent

More information

LV Distension and ECLS Lungs

LV Distension and ECLS Lungs LV Distension and ECLS Lungs Kevin W. Hatton, MD, FCCM Interim Vice-Chair for Anesthesiology Research Division Chief, Anesthesiology Critical Care Medicine Program Director, Anesthesiology Critical Care

More information

Option and Pitfalls in Cannulation for Extracorporeal Support

Option and Pitfalls in Cannulation for Extracorporeal Support Option and Pitfalls in Cannulation for Extracorporeal Support The Regensburg Experience Extracorporeal Life Support Group Dept. of Anaesthesiology Dept. of Internal Medicine Dept. of Cardiothoracic Surgery

More information

Interesting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart. O Wenker, L Chaloupka, R Joswiak, D Thakar, C Wood, G Walsh

Interesting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart. O Wenker, L Chaloupka, R Joswiak, D Thakar, C Wood, G Walsh ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 3 Number 2 Interesting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart O Wenker, L Chaloupka, R

More information

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006)

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Principal Developer: V. Oliva Secondary Developers: W. Geerts Background The treatment of choice for deep venous thrombosis (DVT) and pulmonary

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)

Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Definition Vascular surgery is the specialty concerned with the diagnosis and management of congenital and acquired diseases of the

More information

Management of Bleeding and Hemolysis. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Professor of

Management of Bleeding and Hemolysis. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Professor of Management of Bleeding and Hemolysis Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Professor of Medicine @DrMauricioCohen Disclosure Statement of Financial Interest Within the

More information

Samphant Ponvilawan Bumrungrad International

Samphant Ponvilawan Bumrungrad International Samphant Ponvilawan Bumrungrad International Definitions Artificial circulation using VA ECMO as an alternative to ventilation and external cardiac massage Indications Out-of-Hospital Cardiac Arrest (OHCA)

More information

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with

More information

Interventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital

Interventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital Interventional Radiology in Trauma Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital Disclosures None relevant to this presentation Shareholder Johnson and Johnson Goal

More information

New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel)

New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel) New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel) Limitations and Advantages of UFH and LMWH Biological limitations of UFH : 1. immune-mediated

More information

Intended Learning Outcomes

Intended Learning Outcomes 2011 Acute Limb Ischemia Definition, Etiology & Pathophysiology Clinical Evaluation Management Ali SABBOUR Prof. of Vascular Surgery, Ain Shams University Acute Limb Ischemia Intended Learning Outcomes

More information

ECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit

ECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit ECMO CPR Ravi R. Thiagarajan MBBS, MPH Staff Intensivist Cardiac Intensive Care Unit Children s Hospital Boston PCICS 2008, Miami, FL No disclosures Disclosures Outline Outcomes for Pediatric in-hospital

More information

Algorithm for Managing Acute Lower Extremity Ischemia. Peter A. Schneider, MD Honolulu, Hawaii

Algorithm for Managing Acute Lower Extremity Ischemia. Peter A. Schneider, MD Honolulu, Hawaii Algorithm for Managing Acute Lower Extremity Ischemia Peter A. Schneider, MD Honolulu, Hawaii Disclosure Peter A. Schneider, MD... I have the following potential conflicts of interest to report: Consulting:

More information

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9 Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...

More information

ECLS. The Basics. Jeannine Hermens Intensive Care Center UMC Utrecht

ECLS. The Basics. Jeannine Hermens Intensive Care Center UMC Utrecht ECLS The Basics Jeannine Hermens Intensive Care Center UMC Utrecht Conflict of interest None Terminology ECMO - ExtraCorporeal Membrane Oxygenation ECLS - ExtraCorporeal Life Support PLS - Veno-venous

More information

Dr Brigitta Brandner UCLH

Dr Brigitta Brandner UCLH Dr Brigitta Brandner UCLH 2.5% paraplegia/paraparesis (EUROSTAR) Some studies up to 8% Immediate, recurrent and delayed 37% deficits are delayed: present 13 hours 91 days post op >50% will resolve with

More information

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS New Horizons In Atherothrombosis Treatment 2012 순환기춘계학술대회 FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS Division of Cardiology, Jeonbuk National University Medical School Jei Keon Chae,

More information

Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease

Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease Kristen Nelson, MD Johns Hopkins University Director, Pediatric Cardiac Critical Care Why Does it Matter? Pediatric

More information

THROMBOTIC DISORDERS: The Final Frontier

THROMBOTIC DISORDERS: The Final Frontier THROMBOTIC DISORDERS: The Final Frontier Jeffrey I. Weitz, MD, FRCP(C), FACP Professor of Medicine and Biochemistry McMaster University Canada Research Chair in Thrombosis Heart & Stroke Foundation/ J.F.

More information

Extracorporeal Membrane Oxygenation (ECMO)

Extracorporeal Membrane Oxygenation (ECMO) Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/01/2014 Section: Other/Miscellaneous

More information

Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care

Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care Disclosures I have no financial disclosures. The use of certain devises for providing long-term cardiopulmonary support is investigational.

More information

Extracorporeal Membrane Oxygenation (ECMO)

Extracorporeal Membrane Oxygenation (ECMO) Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2017 Section: Other/Miscellaneous

More information

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER Page 1 of 5 ASPIRATION CATHETER Carefully read all instructions prior to use, observe all warnings and precautions noted throughout these instructions. Failure to do so may result in complications. STERILE.

More information

Initial Experience With Single Cannulation for Venovenous Extracorporeal Oxygenation in Adults

Initial Experience With Single Cannulation for Venovenous Extracorporeal Oxygenation in Adults Initial Experience With Single Cannulation for Venovenous Extracorporeal Oxygenation in Adults Christian A. Bermudez, MD, Rodolfo V. Rocha, MD, Penny L. Sappington, MD, Yoshiya Toyoda, MD, PhD, Holt N.

More information

4/23/2009. September 15, 2008

4/23/2009. September 15, 2008 The Current Treatment of Deep Venous Thrombosis: Are We Doing Enough? George H. Meier, MD Professor and Chief Division of Vascular Surgery University of Cincinnati College of Medicine Cincinnati, Ohio

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

Challenges in Anticoagulation and Thromboembolism

Challenges in Anticoagulation and Thromboembolism Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011

Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011 Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011 Susan E. Wiegers, MD, FASE Director of Clinical Echocardiography Hospital of the University of Pennsylvania Disclosure

More information

Section 3: Prevention and Treatment of AKI

Section 3: Prevention and Treatment of AKI http://www.kidney-international.org & 2012 KDIGO Summary of ommendation Statements Kidney International Supplements (2012) 2, 8 12; doi:10.1038/kisup.2012.7 Section 2: AKI Definition 2.1.1: AKI is defined

More information

The Role of ECMO in Thoracic Surgery. Matthew Hartwig, MD

The Role of ECMO in Thoracic Surgery. Matthew Hartwig, MD The Role of ECMO in Thoracic Surgery Matthew Hartwig, MD Disclosure Slide Consultant for Mallincrodkt and Quark Pharmaceuticals Case #1 28 y.o. female with tracheal mass No previous medical or surgical

More information

AORTIC GRAFT INFECTION

AORTIC GRAFT INFECTION NURSING CARE Theresa O Keefe NUM Vascular Unit PAH Vascular infections are serious They are associated with high morbidity and mortality The primary cause of surgical wound infections is contamination

More information

RESUSCITATION IN TRAUMA. Important things I have learnt

RESUSCITATION IN TRAUMA. Important things I have learnt RESUSCITATION IN TRAUMA Important things I have learnt Trauma resuscitation through the decades What was hot and now is not 1970s 1980s 1990s 2000s Now 1977 Fluids Summary Dogs subjected to arterial hemorrhage

More information

Extra Corporeal Life Support for Acute Heart failure

Extra Corporeal Life Support for Acute Heart failure Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical

More information

Thrombolysis Delivery, Care, and Monitoring. 5 Acute Trusts - 6 Primary Care Trusts Ambulance Trust 4 Local Authorities

Thrombolysis Delivery, Care, and Monitoring. 5 Acute Trusts - 6 Primary Care Trusts Ambulance Trust 4 Local Authorities Thrombolysis Delivery, Care, and Monitoring Documentation & Pathways Need to follow locally agreed policies and procedures Follow thrombolysis pathway? Need to complete Sits database Weight Dose matters!

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

FOCUS CONFERENCE 2018

FOCUS CONFERENCE 2018 FOCUS CONFERENCE 2018 Current Practice in Pediatric and Neonatal Extracorporeal Life Support Daniel W. Chipman, RRT Assistant Director of Respiratory Care Massachusetts General Hospital Boston, Massachusetts

More information

ECMO vs. CPB for Intraoperative Support: How do you Choose?

ECMO vs. CPB for Intraoperative Support: How do you Choose? ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis

More information

Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio

Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio Biventricular Heart Failure Advanced Treatment Options at The Cleveland Clinic Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio I have no disclosures. Examine respiratory and

More information

ECLS Registry Form Extracorporeal Life Support Organization (ELSO)

ECLS Registry Form Extracorporeal Life Support Organization (ELSO) ECLS Registry Form Extracorporeal Life Support Organization (ELSO) Center ID: Center name: Run No (for this patient) Unique ID: Birth Date/Time Sex: (M, F) Race: (Asian, Black, Hispanic, White, Other)

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

A 50-year-old woman with syncope

A 50-year-old woman with syncope Hira Shahzad 1, Ali Bin Sarwar Zubairi 2 1 Medical College, Aga Khan University Hospital, Karachi 2 Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan Ali Bin Sarwar Zubairi Associate

More information

NOTE: Deep Vein Thrombosis (DVT) Risk Factors

NOTE: Deep Vein Thrombosis (DVT) Risk Factors Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the

More information

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize The Role of Mechanical Circulatory Support in Cardiogenic Shock: Presented by Nancy Scroggins ACNP, CNS-CC CV Surgery ACNP Bayshore Medical Center The Role of Mechanical Circulatory Support in Cardiogenic

More information

Patient Brochure. Clearstream Technologies, Ltd. Moyne Upper Enniscorthy Co. Wexford, Ireland. PK Rev. 0 05/17

Patient Brochure. Clearstream Technologies, Ltd. Moyne Upper Enniscorthy Co. Wexford, Ireland. PK Rev. 0 05/17 Patient Brochure Clearstream Technologies, Ltd. Moyne Upper Enniscorthy Co. Wexford, Ireland PK1411100 Rev. 0 05/17 LIFESTREAM Patient Brochure If you or a member of your family has been diagnosed with

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACTIVASE (t-pa) FOR ACUTE MYOCARDIAL INFARCTION I. PURPOSE: A. To reduce the extent of myocardial infarction by lysing the clot in

More information

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

Surgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine

Surgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &

More information

Troubleshooting Adult ECMO

Troubleshooting Adult ECMO The Journal of ExtraCorporeal Technology Troubleshooting Adult ECMO David Sidebotham, FANZCA Departments of Anaesthesia and Intensive Care, Auckland City Hospital, Auckland, New Zealand Presented at Perfusion

More information

ECMO for cardiac arrest patients: Update 2017

ECMO for cardiac arrest patients: Update 2017 ECMO for cardiac arrest patients: Update 2017 Lim Swee Han MBBS (NUS), FRCS Ed (A&E), FRCP (Edin), FAMS Senior Consultant, Department of Emergency Medicine, Singapore General Hospital Adjunct Associate

More information

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know! Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know! Matthew A. Wanat, PharmD, BCPS, BCCCP, FCCM Clinical Assistant Professor University of Houston College of Pharmacy Clinical Pharmacy

More information

Central Venous Line Insertion

Central Venous Line Insertion Central Venous Line Insertion Understand the indications and risks of CVC insertion Understand and troubleshoot the seldinger technique Understand available sites and select the appropriate site for clinical

More information

Introduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6

Introduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6 Patient Information Table of Contents Introduction 3 What is Peripheral Vascular Disease? 5 What Are Some of the Symptoms of Peripheral Vascular Disease? 6 What Causes Peripheral Vascular Disease? 7 How

More information

Frequently Asked Questions about Cancer Associated Thrombosis

Frequently Asked Questions about Cancer Associated Thrombosis + Frequently Asked Questions about Cancer Associated Thrombosis Atlantic Canada Oncology Group Annual Meeting June 13 th, 2015 Sudeep Shivakumar, Dalhousie University + Conflict of Interest Disclosures

More information

Adult Extracorporeal Life Support (ECLS)

Adult Extracorporeal Life Support (ECLS) Adult Extracorporeal Life Support (ECLS) Steven Scott, M.D., F.A.C.S. Piedmont Heart Institute Cardiothoracic Surgery Disclosures None ECMO = ECLS A technique of life support that involves a continuous

More information

Resident Teaching Conference 3/12/2010

Resident Teaching Conference 3/12/2010 Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute

More information

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D. Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators

More information

Extracorporeal support in acute respiratory failure. Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London

Extracorporeal support in acute respiratory failure. Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London Extracorporeal support in acute respiratory failure Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London Objectives By the end of this session, you will be able to: Describe different

More information

Obesity, renal failure, HIT: which anticoagulant to use?

Obesity, renal failure, HIT: which anticoagulant to use? Obesity, renal failure, HIT: which anticoagulant to use? Mark Crowther with thanks to Dr David Garcia and others. This Photo by Unknown Author is licensed under CC BY-SA 1 2 Drug choices The DOACs have

More information

Which Cyanotic Patient Needs Anticoagulation?

Which Cyanotic Patient Needs Anticoagulation? Which Cyanotic Patient Needs Anticoagulation? Erwin Oechslin, MD, FRCPC, FESC Director, Adult Congenital Heart Disease Program The Bitove Family Professor of ACHD Professor of Medicine, U of T Peter Munk

More information

Section 6 Intra Aortic Balloon Pump

Section 6 Intra Aortic Balloon Pump Section 6 Intra Aortic Balloon Pump The Intra Aortic Balloon Pump (IABP) The balloon is synthetic and is made for single use only. It is threaded into the aorta, usually via a femoral approach. The balloon

More information

Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report

Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report The Leipzig Interventional Course, January 24 27, 2017 El Samman K., Šedivý P., Šnajdrová A., Přindišová

More information

Topic 4: Fractures and External Fixation

Topic 4: Fractures and External Fixation Topic 4: Fractures and External Fixation Acute Compartment Syndrome Prof. Dr. Andreas Platz Stadtspital Triemli, Zürich Demographics Incidence: Men 7.3/100,000 Women 0.7/100,000 69% due to trauma 36% fx

More information

P-RMS: LT/H/PSUR/0004/001

P-RMS: LT/H/PSUR/0004/001 Core Safety Profile Active substance: Dalteparine Pharmaceutical form(s)/strength: Solution for injection, 2500 I.U./0.2ml, 2500 I.U./ml, 5000 I.U./0.2ml, 7500 I.U./0.3ml, 7500 I.U./0.75ml, 10000 I.U./0.4ml,

More information

Recent advances in CRRT

Recent advances in CRRT Recent advances in CRRT JAE IL SHIN, M.D., Ph.D. Department of Pediatrics, Severance Children s Hospital, Yonsei University College of Medicine, Seoul, Korea Pediatric AKI epidemiology and demographics

More information

An emerging problem: Vascular access for ECMO

An emerging problem: Vascular access for ECMO An emerging problem: Vascular access for ECMO Dott.ssa Maria Grazia Calabrò U.O. Anestesia e Terapia Intensiva Cardio-Toraco-Vascolare Ospedale San Raffaele, Milano Impossibile visualizzare l'immagine.

More information

Admission Day 2 Na Potassium Cl Bicarb BUN Cr Hb Hct platelets

Admission Day 2 Na Potassium Cl Bicarb BUN Cr Hb Hct platelets Nithin Karakala Mr. Clark Kent was admitted to the hospital with multiple injuries after an epic battle with the Kryptonians. He was hypotensive at the time of admission. Over the next 24 hours he develops

More information

Combat Extremity Vascular Trauma

Combat Extremity Vascular Trauma Combat Extremity Vascular Trauma Training teams to be a TEAM Chatt A. Johnson LTC, MC, USA 08 March 2010 US Army Trauma Training Center Core Discussion Series Outline: Combat Vascular Injury Physiologic

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE VENOUS THROMBOEMBOLISM PROPHYLAXIS SCOPE Provincial Acute and Sub-Acute Care Facilities APPROVAL AUTHORITY Alberta Health Services Executive Committee SPONSOR Vice President, Quality and Chief Medical

More information

Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA

Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA ISES Online Neurological Complications of Frank J Criado, MD TEVAR Union Memorial-MedStar Health Baltimore, MD USA frank.criado@medstar.net Paraplegia Incidence is 0-4% after surgical Rx of TAAs confined

More information

DVT - initial management NSCCG

DVT - initial management NSCCG Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is

More information

EAST MULTICENTER STUDY DATA DICTIONARY. Temporary Intravascular Shunt Study Data Dictionary

EAST MULTICENTER STUDY DATA DICTIONARY. Temporary Intravascular Shunt Study Data Dictionary EAST MULTICENTER STUDY DATA DICTIONARY Temporary Intravascular Shunt Study Data Dictionary Data Entry Points and appropriate definitions / clarifications: Entry space Definition / Instructions 1. Specific

More information

Pre-operative usage of IABP for patients for by pass surgery

Pre-operative usage of IABP for patients for by pass surgery Pre-operative usage of IABP for patients for by pass surgery Mitrev Z, Anguseva T, Hristov N Special hospital for surgery Filip Vtori Skopje - Macedonija Oktomvri, 2008 IABP Background Preload Afterload

More information

Endovascular Trauma Management. Thomas Larzon, MD, PhD Dep of Cardiothoracic and Vascular Surgery Örebro University Hospital, Sweden

Endovascular Trauma Management. Thomas Larzon, MD, PhD Dep of Cardiothoracic and Vascular Surgery Örebro University Hospital, Sweden Endovascular Trauma Management Thomas Larzon, MD, PhD Dep of Cardiothoracic and Vascular Surgery Örebro University Hospital, Sweden Medtronic Symposium, LINC 2016 Disclosures I have the following potential

More information

What is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic

What is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic What is the optimal time window for treating deep venous thrombosis? Acute vs subacute vs chronic Peter A. Schneider, MD Chief of Vascular Therapy Kaiser Foundation Hospital Honolulu, Hawaii Disclosure

More information

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting Disclosure Thrombolysis in PE Daniel P. Hays, PharmD, BCPS, FASHP reports no relevant financial relationships. Daniel P. Hays, PharmD, BCPS, FASHP Outline 55 YOF presents to ED with SOB PMH of DVT + noncompliance

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? TRAUMA SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and

More information

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.

More information

Interventional treatment for patients with acute pulmonary embolism

Interventional treatment for patients with acute pulmonary embolism Interventional treatment for patients with acute pulmonary embolism I. Petrov, I. Martinov Cardiology department Tokuda Hospital Sofia I. Petrov, Treatment and prophylaxis of PE Treatment of PE: 1.) Systemic

More information

Comparison of Five Major Recent Endovascular Treatment Trials

Comparison of Five Major Recent Endovascular Treatment Trials Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline

More information

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism

More information

ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest

ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest ECMO: a breakthrough in care for respiratory failure? PD Dr. Thomas Müller Regensburg no conflict of interest 1 Overview Mortality of severe ARDS Indication for ECMO PaO 2 /FiO 2 Efficiency of ECMO: gas

More information

Atrial Septostomy in HLHS and ECMO: Indications, Technique and Outcome

Atrial Septostomy in HLHS and ECMO: Indications, Technique and Outcome Atrial Septostomy in HLHS and ECMO: Indications, Technique and Outcome Dr Damien Kenny, MB, MD Assistant Professor of Pediatrics Director of the Cardiac Catheterization Hybrid Suite Co-Director of the

More information

What are blood clots?

What are blood clots? What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew

More information

CURRENT STATUS OF EXTRACORPOREAL LIFE SUPPORT FOR CARDIOPULMONARY FAILURE

CURRENT STATUS OF EXTRACORPOREAL LIFE SUPPORT FOR CARDIOPULMONARY FAILURE CURRENT STATUS OF EXTRACORPOREAL LIFE SUPPORT FOR CARDIOPULMONARY FAILURE Dr Susanna Price MBBS BSc MRCP EDICM PhD FFICM FESC Consultant Cardiologist & Intensivist Royal Brompton Hospital, London DECLARATION

More information

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI How to manage TAVI related vascular complications Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI Definition VARC-2 consensus statement Complications caused by: Wire Catheter Anything related to vascular access

More information

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT

More information